medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2020, Number 3

<< Back Next >>

Acta Med 2020; 18 (3)

Dieulafoy’s rectal injury: A rare but potentially fatal cause of lower GI bleeding

Gallo AB, Nieto SJR, Gallo CB, Ibarra RJJ, Santibáñez BKE, Hidalgo VC

Language: Spanish
References: 7
Page: 302-305
PDF size: 145.38 Kb.


ABSTRACT

Gastrointestinal bleeding is a frequent disease in consultation and in the emergency room which has very different etiologies. Dieulafouy’s lesion, described for the first time in 1898 is one of the rarest but potentially mortal lesion because of its diagnostic difficulty. We present the case of an 81 year old male patient who arrived to the hospital with a right inferior lobar pneumonia, bacterial endocarditis, acute chronic renal failure and autoimmune thrombocytopenia. During the hospital evolution the patient started with gastrointestinal bleeding that produced an hypovolemic shock twice, during the second colonoscopy in the colonoscope extraction approximately at 12 cm from the anal margin we found an aberrant arterial vessel with active bleeding. We performed hemostasis with diluted adrenalin 1:10,000 and with application of two endoclips with the complete resolution of the bleeding. The patient recovered from the hypovolemic shock with no signs of a new bleeding; nevertheless, he died two weeks after the bleeding event with a multiple organic failure secondary to another pneumonia.


REFERENCES

  1. Khan R, Mahmad A, Gobrial M, Onwochei F, Shah K. The diagnostic dilemma of Dieulafoy’s lesion. Gastroenterol Res. 2015; 8 (3-4): 201-206. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27785297

  2. Nadhem ON, Salh OA, Bazzaz OH. Lower gastrointestinal bleeding due to rectal Dieulafoy’s lesion. SAGE Open Med Case Reports. 2017; 5: 2050313X1774498.

  3. Jeon HK, Kim GH. Endoscopic management of Dieulafoy’s lesion. Clin Endosc. 2015; 48 (2): 112-120.

  4. Tursi A. Rectal Dieulafoy lesion. Clin Res Hepatol Gastroenterol. 2017; 41 (1): 1-2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26186876

  5. Shin HJ, Ju JS, Kim KD, Kim SW, Kang SH, Kang SH et al. Risk factors for Dieulafoy lesions in the upper gastrointestinal tract. Clin Endosc. 2015; 48 (3): 228-233.

  6. Lara LF, Sreenarasimhaiah J, Tang S, Afonso BB, Rockey DC. Dieulafoy lesions of the GI tract: localization and therapeutic outcomes. Dig Dis Sci. 2010; 55 (12): 3436-3441. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20848205

  7. Chung I-K, Kim E-J, Lee M-S, Kim H-S, Park S-H, Lee M-H, et al. Bleeding Dieulafoy’s lesions and the choice of endoscopic method: Comparing the hemostatic efficacy of mechanical and injection methods. Gastrointest Endosc. 2000; 52 (6): 721-724. Available from: https://www.sciencedirect.com/science/article/pii/S0016510700701830




2020     |     www.medigraphic.com